Latest Ratings for DT Date Firm Action From To Feb 2022 Rosenblatt Maintains Buy Feb 2022 BTIG Downgrades Buy Neutral Feb 2022 Needham Maintains Buy View More Analyst Ratings for DT View the Latest Analyst Ratings read more
Latest Ratings for PGNY Date Firm Action From To Dec 2021 Jefferies Initiates Coverage On Buy Sep 2021 Berenberg Initiates Coverage On Buy Sep 2021 Barclays Maintains Overweight View More Analyst Ratings for PGNY View the Latest Analyst Ratings read more
The Trump family has significantly increased its control over World Liberty Financial, a decentralized finance platform still under development. read more
A Congressman who bought shares of a Bitcoin (CRYPTO: BTC) ETF before President Donald Trump announced an Executi read more
Gold prices exceeded $3,000/oz, with potential to reach $3,500 if investment demand rises. China’s insurance sector and central banks may increase gold holdings, while ETF inflows signal growing retail interest. Trade policy uncertainty and a weaker U.S. dollar could further support prices. Latest Ratings for GOLD Date Firm Action From To Mar 2022 Jefferies Maintains…
On March 27, Alphabet Inc (NASDAQ:GOOG) (NASDAQ:GOOGL) Google introduced several new features across Search, Maps, and Gemini Latest Ratings for GOOGL Date Firm Action From To Feb 2022 MKM Partners Maintains Buy Feb 2022 Mizuho Maintains Buy Feb 2022 Piper Sandler Maintains Overweight View More Analyst Ratings for GOOGL View the Latest Analyst Ratings read…
FDA approved AstraZeneca’s Imfinzi regimen for muscle-invasive bladder cancer, while the EU backed Calquence combo for untreated mantle cell lymphoma. read more